Opportunity Information: Apply for RFA 482 16 000001
Apply for RFA 482 16 000001
- The USAID-BMA in the health sector is offering a public funding opportunity titled "Defeat Malaria" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on Feb 26, 2016 and posted on Feb 26, 2016.
- Applicants must submit their applications by Apr 07, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $32,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Defeat Malaria grant opportunity (Funding Opportunity Number RFA 482 16 000001) is a USAID-Burma (USAID-BMA) discretionary health funding call designed to help Burma meet its national objective of controlling artemisinin-resistant malaria and moving toward full malaria elimination. The program is structured as a cooperative agreement, meaning the recipient would implement the activity with substantial involvement from USAID during the life of the award, which is common for complex public health programs that require close coordination, adaptive management, and alignment with national strategies.
Funding is capped at USD 32,000,000 over a five-year period, and USAID anticipated making one award. The opportunity was posted on February 26, 2016, with an application deadline of April 7, 2016. Eligibility is listed as unrestricted, indicating that a wide range of entities could apply (such as nonprofits, for-profits, universities, and other organizations), subject to any further eligibility conditions that may have been specified in the full announcement.
Programmatically, Defeat Malaria is centered on scaling up community-based malaria prevention and case management, expanding coverage from roughly one million people to three million people. The emphasis is explicitly on populations and geographies that tend to be missed by standard health service delivery: highly endemic and hard-to-reach areas, mobile and migrant groups, and locations governed or influenced by non-state actors. This focus reflects the operational reality that malaria elimination depends on reaching transmission hotspots and ensuring that people who move frequently or live outside routine government service areas still have consistent access to prevention tools and prompt diagnosis and treatment.
A major pillar of the activity is strengthening local capacity at every level of the health system and stakeholder landscape, from national institutions down to peripheral and community levels. The intent is not only to deliver services directly, but to build the leadership, management, and implementation capabilities needed for sustained malaria control and eventual elimination. In practice, this kind of capacity strengthening typically involves training, supportive supervision, supply chain and logistics improvements, data use and decision-making support, and coordination mechanisms that enable government and local partners to plan and execute interventions effectively.
The opportunity also places strong weight on improving malaria surveillance so that response and control strategies can be better informed by timely, accurate data. Strong surveillance is essential in elimination settings, where the goal shifts from broad burden reduction to identifying cases quickly, investigating transmission sources, and targeting interventions to prevent onward spread. Alongside surveillance improvements, the activity seeks to promote deeper involvement of communities and the private sector in malaria control initiatives, recognizing that community acceptance and private providers (often a first point of care) can significantly influence early diagnosis, correct treatment, reporting, and adherence to prevention measures.
Overall, Defeat Malaria is positioned as a large, five-year investment to expand frontline community services, focus resources on the most difficult and highest-risk settings, build durable local implementing capacity, and strengthen surveillance and multi-sector engagement to address drug-resistant malaria and accelerate progress toward nationwide elimination in Burma.
Defeat Malaria (USAID-Burma) Grant Opportunity: FAQs
1. What is the Defeat Malaria grant opportunity?
The Defeat Malaria grant opportunity is a USAID-Burma (USAID-BMA) discretionary health funding call designed to help Burma meet its national objective of controlling artemisinin-resistant malaria and moving toward full malaria elimination.
2. What is the Funding Opportunity Number (FON) for this opportunity?
The Funding Opportunity Number is RFA 482 16 000001.
3. What type of award is being offered?
This opportunity is structured as a cooperative agreement. Under a cooperative agreement, the recipient implements the activity with substantial involvement from USAID during the life of the award. This structure is commonly used for complex public health programs that require close coordination, adaptive management, and alignment with national strategies.
4. How much funding is available?
Funding is capped at USD 32,000,000 over a five-year period.
5. How long is the project period?
The anticipated period of performance is five years.
6. How many awards did USAID anticipate making?
USAID anticipated making one award.
7. When was the opportunity posted?
The opportunity was posted on February 26, 2016.
8. What was the application deadline?
The application deadline was April 7, 2016.
9. Who is eligible to apply?
Eligibility is listed as unrestricted, which indicates that a wide range of entities could apply (such as nonprofits, for-profits, universities, and other organizations), subject to any further eligibility conditions that may have been specified in the full announcement.
10. What is the main goal of the Defeat Malaria program?
The program is designed to support Burma in controlling artemisinin-resistant malaria and accelerating progress toward full malaria elimination.
11. What is artemisinin-resistant malaria, and why does it matter for this program?
Artemisinin-resistant malaria is specifically highlighted as the programmatic focus, and controlling it is tied to Burma's national objective. The opportunity positions drug resistance as a key challenge that must be addressed to make progress toward elimination.
12. What program approach is emphasized?
Defeat Malaria is centered on scaling up community-based malaria prevention and case management, with a strong focus on expanding access in areas and among populations that are often missed by standard health service delivery.
13. What scale-up in population coverage is expected?
The activity aims to expand coverage from roughly one million people to three million people.
14. Which populations and settings are prioritized?
The opportunity explicitly prioritizes:
- Highly endemic and hard-to-reach areas
- Mobile and migrant groups
- Locations governed or influenced by non-state actors
This reflects the operational reality that elimination depends on reaching transmission hotspots and ensuring consistent access to prevention, diagnosis, and treatment for people outside routine government service areas.
15. What does "community-based malaria prevention and case management" imply in this opportunity?
Based on the description provided, the opportunity emphasizes frontline, community-level delivery of prevention services and timely case management (diagnosis and treatment) to reduce transmission and support elimination goals, especially in underserved geographies and among high-risk groups.
16. How important is local capacity strengthening in this program?
Local capacity strengthening is described as a major pillar of the activity. The intent is not only to deliver services directly, but to build leadership, management, and implementation capabilities needed for sustained malaria control and eventual elimination.
17. What levels of the health system are targeted for capacity strengthening?
The opportunity indicates strengthening local capacity "at every level," ranging from national institutions down to peripheral and community levels, and across the broader stakeholder landscape involved in malaria control.
18. What kinds of capacity-strengthening activities are generally associated with this program?
The description notes that this kind of capacity strengthening typically involves:
- Training
- Supportive supervision
- Supply chain and logistics improvements
- Data use and decision-making support
- Coordination mechanisms that help government and local partners plan and execute interventions
19. What role does malaria surveillance play in the opportunity?
Improving malaria surveillance is given strong weight. The opportunity emphasizes that timely, accurate data are essential, especially in elimination settings where programs must identify cases quickly, investigate sources, and target interventions to prevent onward spread.
20. Why is surveillance especially important in elimination settings?
The opportunity explains that as countries move toward elimination, the focus shifts from broad burden reduction to rapidly detecting and responding to cases, investigating transmission sources, and directing interventions to stop further transmission.
21. Does the opportunity mention engagement beyond the public health system?
Yes. The activity seeks deeper involvement of both communities and the private sector in malaria control initiatives.
22. Why does the opportunity emphasize community involvement?
The opportunity recognizes that community acceptance can significantly influence early diagnosis, correct treatment, reporting, and adherence to prevention measures, which are all critical in controlling drug-resistant malaria and advancing elimination goals.
23. Why does the opportunity emphasize private sector involvement?
The opportunity notes that private providers are often a first point of care and can significantly influence early diagnosis, correct treatment, reporting, and adherence to prevention measures.
24. How does the cooperative agreement structure affect implementation?
Because this is a cooperative agreement, the recipient would implement the activity with substantial involvement from USAID throughout the award. This implies close coordination and alignment with national strategies, with adaptive management commonly expected for complex public health programming.
25. What is the overall intent of the five-year investment described?
Defeat Malaria is positioned as a large, five-year investment to:
- Expand frontline community services
- Focus resources on the most difficult and highest-risk settings
- Build durable local implementing capacity
- Strengthen surveillance
- Increase multi-sector engagement (communities and private sector)
All of these elements are aimed at addressing drug-resistant malaria and accelerating progress toward nationwide malaria elimination in Burma.
Browse more opportunities from the same category: Health
Next opportunity: Office of Special Education and Rehabilitative Services (OSERS): Office of Special Programs (OSEP): Training and Information for Parents of Children with Disabilities: Community Parent Resource Centers CFDA Number 84.328C
Previous opportunity: W.E.B. DuBois Program of Research on Race and Crime
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA 482 16 000001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA 482 16 000001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Improving Response to and Programming in Humanitarian Emergencies Apply for CDC RFA GH15 162302CONT16 Funding Number: CDC RFA GH15 162302CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Pragmatic Strategies for Assessing Psychotherapy Quality in Practice (R01) Apply for RFA MH 17 500 Funding Number: RFA MH 17 500 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Small Vessel Vascular Contributions to Cognitive Impairment and Dementia (VCID) Biomarkers Development Projects (UH2/UH3) Apply for RFA NS 16 020 Funding Number: RFA NS 16 020 Agency: HHS-NIH11 Category: Health Funding Amount: $750,000 |
| Partner Support for Heart Disease and Stroke Prevention Apply for CDC RFA DP15 150402CONT16 Funding Number: CDC RFA DP15 150402CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome Apply for CDC RFA DD15 150502CONT16 Funding Number: CDC RFA DD15 150502CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strategic Approaches to Improving Access to Quality Health Care for Children and Youth with Epilepsy Apply for HRSA 16 055 Funding Number: HRSA 16 055 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Developing professional training programs to increase capacity for effective global health response to humanitarian emergencies Apply for CDC RFA GH15 162402CONT16 Funding Number: CDC RFA GH15 162402CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Programs to Reduce Obesity in High Obesity Areas Apply for CDC RFA DP14 141603CONT16 Funding Number: CDC RFA DP14 141603CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| PPHF 2016: Office of Smoking and Health – Public Health Approaches for Ensuring Quitline Capacity – Financed solely by 2016 Prevention and Public Health Funds Apply for CDC RFA DP14 141003CONTPPHF16 Funding Number: CDC RFA DP14 141003CONTPPHF16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Targeted Capacity Expansion HIV: Substance Use Disorder Treatment for Racial/Ethnic Minority Women at High Risk for HIV/AIDS (Short Title: TCE-HIV: Minority Women) Apply for TI 16 011 Funding Number: TI 16 011 Agency: HHS-SAMHS-SAMHSA Category: Health Funding Amount: $500,000 |
| PPHF 2016: National Early Child Care Collaboratives - Early Care and Education Statewide Collaboratives to Improve Nutrition, Breastfeeding Support, Physical Activity and Screen Time Practices for Obesity Prevention in Young Children Apply for CDC RFA DP12 121505CONTPPHF16 Funding Number: CDC RFA DP12 121505CONTPPHF16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Early Childhood Comprehensive Systems Collaborative Improvement and Innovation Network Coordination Center (ECCS CoIIN CC) Apply for HRSA 16 179 Funding Number: HRSA 16 179 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Development, Maintenance and Enhancement of Early Hearing Detection and Intervention Information System (EHDI-IS) Surveillance Programs Apply for CDC RFA DD16 1604 Funding Number: CDC RFA DD16 1604 Agency: HHS-CDC-NCBDDD Category: Health Funding Amount: $175,000 |
| Pediatric Environmental Health Specialty Unit (PEHSU) Program Apply for CDC RFA TS14 140203CONT16 Funding Number: CDC RFA TS14 140203CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Service Area Competition – Additional Area (SAC-AA) – Tacoma, Washington Apply for HRSA 16 184 Funding Number: HRSA 16 184 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Serve as the U.S. Partner within the global STOP TB Partnership and participate in STOP TB Partnership activities Apply for CDC RFA PS12 120805CONT16 Funding Number: CDC RFA PS12 120805CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Strengthening Public Health Laboratories Apply for CDC RFA OE15 150102CONT16 Funding Number: CDC RFA OE15 150102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Viral Hepatitis Networking, Capacity Building, and Training Apply for CDC RFA PS16 1608 Funding Number: CDC RFA PS16 1608 Agency: HHS-CDC-NCHHSTP Category: Health Funding Amount: $650,000 |
| Improving the Impact of Laboratory Practice Guidelines: A New Paradigm for Metrics Apply for CDC RFA OE13 130404CONT16 Funding Number: CDC RFA OE13 130404CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Life Course Research Network Apply for HRSA 16 033 Funding Number: HRSA 16 033 Agency: HHS-HRSA Category: Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA 482 16 000001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.